With 0.69 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.58 million shares. During the session, the Insurance – Specialty company that operates in wider Financial sector, reached to the highest price of $56.95 whereas the lowest price it dropped to was $56.34. The 52-week range on ESNT shows that it touched its highest point at $65.33 and its lowest point at $47.56 during that stretch. It currently has a 1-year price target of $65.56. With its current market cap of 6.12 billion, ESNT has annualized dividend of $1.09 while the current yield stands at 1.92%. Beta for the stock currently stands at 1.10.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ESNT was up-trending over the past week, with a rise of 2.27%, but this was down by -7.80% over a month. Three-month performance dropped to -9.82% while six-month performance rose 1.01%. The stock gained 17.66% in the past year, while it has gained 7.62% so far this year. A look at the trailing 12-month EPS for ESNT yields 6.90 with Next year EPS estimates of 6.95. For the next quarter, that number is 1.65. This implies an EPS growth rate of 6.21% for this year and 0.60% for next year. EPS is expected to grow by 3.08% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 6.38%.
Float and Shares Shorts:
At present, 106.60 million ESNT shares are outstanding with a float of 102.85 million shares on hand for trading. On 2024-10-31, short shares totaled 1.08 million, which was 101.99999 higher than short shares on 1727654400. In addition to Mr. Mark Anthony Casale as the firm’s Chairman, CEO & President, Mr. David Bruce Weinstock serves as its CFO & Senior VP.
Institutional Ownership:
Through their ownership of 0.95328003 of ESNT’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ESNT since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ESNT analysts setting a high price target of 73.0 and a low target of 60.0, the average target price over the next 12 months is 65.55556. Based on these targets, ESNT could surge 28.61% to reach the target high and rise by 5.71% to reach the target low. Reaching the average price target will result in a growth of 15.5% from current levels.
Analysts have provided yearly estimates in a range of $7.03263 being high and $6.77437 being low. For ESNT, this leads to a yearly average estimate of $6.9035. The surprise factor in the prior quarter was $1.68. Based on analyst estimates, the high estimate for the next quarter is $1.88 and the low estimate is $1.59. The average estimate for the next quarter is thus $1.72.
